UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 4, 2009

PERFORMANCE HEALTH TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-52647	841474432
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

427 Riverview Plaza, Trenton, NJ		08611
(Address of Principal Executive Offices)		(Zip Code)

Our telephone number, including area code: (609) 656-0800

		Not Applicable
		(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of us under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 5—Corporate Governance and Management

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On April 4, 2009, David J. Lenihan resigned as a Director of Performance Health Technologies, Inc. (the “Company”).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on our behalf by the undersigned hereunto duly authorized.

Date: April 7, 2009

	PERFORMANCE HEALTH TECHNOLOGIES, INC. (Registrant)

	By:	/s/ Robert D. Prunetti
		Robert D. Prunetti
		Chief Executive Officer

PERFORMANCE HEALTH TECHNOLOGIES INC 8-K